EGRX STOCKHOLDERS: Robbins LLP Reminds Eagle Pharmaceuticals Shareholders of Pending Lead Plaintiff Deadline – February 9, 2024 Eagle Pharmaceuticals, Inc. (EGRX) Misled Investors and Overstated its Revenue

Eagle Pharmaceuticals Shareholders Still Have Time to Participate in the EGRX Class Action; Contact Robbins LLP Today Eagle Pharmaceuticals, Inc. (EGRX) Misled Investors and Overstated its Revenue

EGRX Class Action Alert: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in Eagle Pharmaceuticals, Inc. Class Action Eagle Pharmaceuticals, Inc. (EGRX) Misled Investors and Overstated its Revenue

Shareholder Alert: Robbins LLP Informs Shareholders of Class Action Filed Against Eagle Pharmaceuticals, Inc. (EGRX) Eagle Pharmaceuticals, Inc. (EGRX) Misled Investors and Overstated its Revenue